Instability of Cancer Cell States in Tumor progression (ICCS)

肿瘤进展过程中癌细胞状态的不稳定性 (ICCS)

基本信息

  • 批准号:
    10491691
  • 负责人:
  • 金额:
    $ 47.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-21 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY ICCS2020-A1 This multi-PI project conducts experiments to study cell state instability in tumor cells, motivated by the theory of “critical transitions” (CT). CTs are abrupt shifts of behavior of a complex non-linear system and are preceded by system state destabilization. A cancer cell population represents a statistical ensemble of cells, each of which is a nonlinear stochastic dynamical system. The latter is embodied by the gene regulatory network (GRN) and cells are normally in stable attractor states. We hypothesize that cancer cells in small lesions can be poised between either staying dormant or exiting dormancy (“escape”) and that this binary decision is a CT. This implies that to be in such a poised state, the cell state has to be destabilized. Thus, detecting cell state instability, manifest in the cell transcriptomes, can discern if a small tumor is safely in a stable state or poised in the above sense. Many an observation suggests that cell density of the dormant tumor may be a “bifurcation parameter” that drives GRN dynamics, via instability toward the CT, at which a cancer cell population can jump to the state of steady growth. SPECIFIC AIMS. The proposed study is experimental but grounded in theory: Cell state instability is manifest in an increase of the quantity IC that we derived from theory and requires single-cell (sc) transcriptomes in a popu- lation to compute (=dynamics of a statistical ensemble of GRNs). Aim 1 (in vitro) uses large ensembles of micro- cultures (=cancer cell populations) to quantitatively show destabilization and bifurcations of growth behaviors. Aim 2 (in vivo) reevaluates old mouse tumor models in a new scheme that exposes the binary decision (dor- mancy vs. “tumor-take”) to test the hypothesis that clinical dormancy escape is preceded by cell state instability. APPROACH: In Aim 1, using massively-parallel micro-cultures, bulk RNASeq and scRNAseq, we examine hith- erto undistinguished growth modes of cancer cells and measure bistability as a function of cell density (dormancy vs. “take-off”). In Aim 2 we examine our intriguing observations in many mouse models: under specific condi- tions, identified by titrating inoculum cell numbers in creating dormant tumors, some mice exhibit stable dor- mancy and others a robust tumor-take despite same initial conditions. This finding suggests a poised state and defines a bistable regime. Tumor models using cells studied in Aim 1 will be evaluated in our scheme to expose bistable behaviors and Ic computed from scRNAseq data. We anticipate that tumors in unstable dormancy poised to take-off display higher cell state instability (higher IC) than the stably dormant tumors. But sc-transcriptomes will also reveal the genes that drive the CT and how they are linked to the risk of impending dormancy escape. SIGNIFICANCE: While this first-in-its-class study analyzes abstract principles rather than specific molecules, its potential impact is tangible: It predicts the fate trajectory of indolent tumors in a new way, complementing current quest for molecular signatures to classify tumors by prognostic groups, by detecting in single-cell resolution cell population data signs of destabilization that herald an approach to the CT or “tipping point” of dormancy escape. This work also raises awareness of non-linear behaviors for the design of more relevant animal tumor models.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amy Brock其他文献

Amy Brock的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amy Brock', 18)}}的其他基金

A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells
一个简化的高通量平台,用于验证癌症抗原呈递和分离癌症抗原反应性 T 细胞
  • 批准号:
    10493222
  • 财政年份:
    2021
  • 资助金额:
    $ 47.94万
  • 项目类别:
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells
一个简化的高通量平台,用于验证癌症抗原呈递和分离癌症抗原反应性 T 细胞
  • 批准号:
    10272349
  • 财政年份:
    2021
  • 资助金额:
    $ 47.94万
  • 项目类别:
Instability of Cancer Cell States in Tumor progression (ICCS)
肿瘤进展过程中癌细胞状态的不稳定性 (ICCS)
  • 批准号:
    10212099
  • 财政年份:
    2021
  • 资助金额:
    $ 47.94万
  • 项目类别:
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance
理解治疗耐药性亚群异质性的系统方法
  • 批准号:
    10057183
  • 财政年份:
    2020
  • 资助金额:
    $ 47.94万
  • 项目类别:
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance
理解治疗耐药性亚群异质性的系统方法
  • 批准号:
    10256717
  • 财政年份:
    2020
  • 资助金额:
    $ 47.94万
  • 项目类别:
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance
理解治疗耐药性亚群异质性的系统方法
  • 批准号:
    10468211
  • 财政年份:
    2020
  • 资助金额:
    $ 47.94万
  • 项目类别:
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance
理解治疗耐药性亚群异质性的系统方法
  • 批准号:
    10524210
  • 财政年份:
    2020
  • 资助金额:
    $ 47.94万
  • 项目类别:
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance
理解治疗耐药性亚群异质性的系统方法
  • 批准号:
    10307901
  • 财政年份:
    2020
  • 资助金额:
    $ 47.94万
  • 项目类别:
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance
理解治疗耐药性亚群异质性的系统方法
  • 批准号:
    10388446
  • 财政年份:
    2020
  • 资助金额:
    $ 47.94万
  • 项目类别:
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance
理解治疗耐药性亚群异质性的系统方法
  • 批准号:
    10759093
  • 财政年份:
    2020
  • 资助金额:
    $ 47.94万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 47.94万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 47.94万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.94万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 47.94万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 47.94万
  • 项目类别:
    Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 47.94万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 47.94万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
  • 批准号:
    23KK0126
  • 财政年份:
    2023
  • 资助金额:
    $ 47.94万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 47.94万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 47.94万
  • 项目类别:
    Training Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了